HUNTINGTON'S DISEASE (HD)
Clinical trials for HUNTINGTON'S DISEASE (HD) explained in plain language.
Never miss a new study
Get alerted when new HUNTINGTON'S DISEASE (HD) trials appear
Sign up with your email to follow new studies for HUNTINGTON'S DISEASE (HD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for Huntington's: new pill targets harmful proteins in Long-Term study
Disease control ENROLLING_BY_INVITATIONThis study tests an oral drug called SKY-0515 in 500 adults with Huntington's disease who have already taken it in a previous study. The goal is to see if the drug can safely lower harmful proteins and improve symptoms over time. Participants must be 25 or older and have a geneti…
Matched conditions: HUNTINGTON'S DISEASE (HD)
Phase: PHASE2, PHASE3 • Sponsor: Skyhawk Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New brain scans aim to catch Huntington's cognitive decline earlier
Knowledge-focused OngoingThis study aims to create more sensitive cognitive tests for Huntington's disease by combining brain imaging (PET and MRI) with blood tests. Researchers will study 90 participants—healthy controls, pre-symptomatic gene carriers, and early-stage patients—to link brain changes with…
Matched conditions: HUNTINGTON'S DISEASE (HD)
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Knowledge-focused
Last updated May 16, 2026 06:05 UTC